Skip to main content
. 2023 May 2;14:100182. doi: 10.1016/j.lansea.2023.100182

Table 1.

Clinical characteristic of the WellGen according to sex.

Characteristic WellGen study (n = 2217)
NGT (PMNS, n = 461)
Male Female All Male Female All p value
No. of participants (%) 1224 (55.2) 993 (44.8) 2217 173 (37.5) 288 (62.5) 461
Age, yearsa 42.04 (9.58) 41.88 (10.25) 41.97 (9.88) 39.80 (4.21) 33.31 (3.29) 35.56 (4.80) 1.35E-31
BMI, kg/m2 25.46 (3.68) 27.27 (4.45) 26.27 (4.14) 21.16 (3.39) 19.74 (2.99) 20.25 (3.21) 8.59E-192
Fasting glucose, mg/dL 8.79 (3.15) 9.04 (3.32) 8.91 (3.23) 4.92 (0.45) 4.79 (0.36) 4.84 (0.40) 3.39E-141
HbA1c, mmol/mol 71.88 (22.59) 71 (22.62) 71.48 (22.6)
HbA1c, % 8.73 (2.07) 8.65 (2.07) 8.69 (2.07)
Fasting C-peptide, nmol/l 0.82 (0.48) 0.83 (0.48) 0.83 (0.48)
HOMA2-B 64.81 (44.3) 64.06 (46.17) 64.48 (45.14) 82.24 (36.67) 85.22 (32.94) 84.14 (34.33) 1.69E-45
HOMA2-IR 2.2 (1.38) 2.24 (1.35) 2.22 (1.37) 0.78 (0.51) 0.79 (0.44) 0.78 (0.47) 7.24E-57

Values are mean (SD).

p-values are calculated using ANOVA (unequal variances) adjusted for age and sex.

NGT: Normal glucose tolerance, PMNS: Pune Maternal Nutrition Study.

a

Age at diabetes diagnosis for WellGen, age at study for PMNS.